PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Smolen, Josef S.
TI  - Results of the GO-AFTER Study
DP  - 2008 Sep 01
TA  - MD Conference Express
PG  - 15--16
VI  - 8
IP  - 5
4099  - http://mdc.sagepub.com/content/8/5/15.short
4100  - http://mdc.sagepub.com/content/8/5/15.full
AB  - This article reviews data from the GO-AFTER Study [NCT00264550], the first prospective, randomized, double-blind, placebo-controlled study that evaluated the efficacy and safety of a TNF inhibitor (golimumab) in patients with active rheumatoid arthritis who were previously exposed to another TNF inhibitor.